Nalmefene Smoking Cessation Study

Clinical trial NCT00202696 · COMPLETED

Trial details

NCT number: NCT00202696
Sponsor: Somaxon Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Smoking Cessation

Start date: 2005-09-01
Primary completion: 2006-03-01
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.